首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity
【24h】

Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity

机译:肿瘤启动但分化的腔样乳腺癌细胞在缺乏基底样活性的情况下具有高度侵袭性

获取原文
获取原文并翻译 | 示例
       

摘要

The majority of human breast cancers exhibit luminal epithelial differentiation. However, most aggressive behavior, including invasion and purported cancer stem cell activity, are considered characteristics of basal-like cells. We asked the following questions: Must luminal-like breast cancer cells become basal-like to initiate tumors or to invade? Could luminally differentiated cells within a basally initiated hierarchy also be tumorigenic? To answer these questions, we used rare and mutually exclusive lineage markers to isolate subsets of luminal-like and basal-like cells from human breast tumors. We enriched for populations with or without prominent basal-like traits from individual tumors or single cell cloning from cell lines and recovered cells with a luminal-like phenotype. Tumor cells with basal-like traits mimicked phenotypic and functional behavior associated with stem cells assessed by gene expression, mammosphere formation and lineage markers. Luminal-like cells without basal-like traits, surprisingly, were fully capable of initiating invasive tumors in NOD SCID gamma (NSG) mice. In fact, these phenotypically pure luminal-like cells generated larger and more invasive tumors than their basal-like counterparts. The tumorigenicity and invasive potential of the luminal-like cancer cells relied strongly on the expression of the gene GCNT1, which encodes a key glycosyltransferase controlling O-glycan branching. These findings demonstrate that basal-like cells, as defined currently, are not a requirement for breast tumor aggressiveness, and that within a single tumor there are multiple "stem-like" cells with tumorigenic potential casting some doubt on the hypothesis of hierarchical or differentiative loss of tumorigenicity.
机译:大多数人类乳腺癌表现出腔上皮分化。然而,大多数侵略性行为,包括侵袭和声称的癌症干细胞活性,被认为是基底样细胞的特征。我们问了以下问题:管腔样乳腺癌细胞是否必须变成基底样才能引发肿瘤或侵袭?基本启动的层次结构中的发光分化细胞是否也具有致瘤性?为了回答这些问题,我们使用了稀有且互斥的谱系标记从人类乳腺肿瘤中分离出腔样细胞和基底样细胞的子集。我们从个体肿瘤中富集了具有或不具有显着的基础样特征或从细胞系和具有管腔样表型的回收细胞中进行单细胞克隆的种群。具有基样特征的肿瘤细胞模仿了与干细胞相关的表型和功能行为,这些行为和功能行为通过基因表达,乳球形成和谱系标记物进行了评估。出乎意料的是,没有基础样特征的类发光细胞完全能够在NOD SCIDγ(NSG)小鼠中引发侵袭性肿瘤。实际上,这些表型纯的腔样细胞比其基底样细胞产生更大,更具侵袭性的肿瘤。腔样癌细胞的致瘤性和侵袭潜力强烈依赖于基因GCNT1的表达,该基因编码控制O-聚糖分支的关键糖基转移酶。这些发现表明,目前定义的基底样细胞并不是乳腺癌侵袭性的必要条件,并且在单个肿瘤中有多个具有肿瘤发生潜力的“茎样”细胞,这对分层或分化假设提出了疑问。致瘤性丧失。

著录项

  • 来源
  • 作者单位

    Department of Cellular and Molecular Medicine, Centre for Biological Disease Analysis and Danish Stem Cell Centre, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark;

    Department of Cellular and Molecular Medicine, Centre for Biological Disease Analysis and Danish Stem Cell Centre, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark;

    Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet,Montebello 0310, Oslo, Norway,Cancer Stem Cell Innovation Center, Oslo University Hospital, Norwegian Radium Hospital, 0310 Oslo, Norway;

    Department of Cellular and Molecular Medicine, Centre for Biological Disease Analysis and Danish Stem Cell Centre, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark;

    Department of Cellular and Molecular Medicine, Centre for Biological Disease Analysis and Danish Stem Cell Centre, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark,Cell and Developmental Biology, Department of Biology, University of Copenhagen, DK-2100 Copenhagen 0, Denmark;

    Department of Cellular and Molecular Medicine, Centre for Biological Disease Analysis and Danish Stem Cell Centre, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark;

    Life Sciences Division, Berkeley National Laboratory, Berkeley, CA 94720;

    Department of Pathology, Rigshospitalet, DK-2100 Copenhagen 0, Denmark;

    Department of Pathology, Rigshospitalet, DK-2100 Copenhagen 0, Denmark;

    Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet,Montebello 0310, Oslo, Norway,Department of Biostatistics, Institute of Basic Medical Science, University of Oslo, 0317 Oslo, Norway;

    Department of Pathology and Hutchison/MRC Research Centre, University of Cambridge, Cambridge CB2 0X2, United Kingdom;

    Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet,Montebello 0310, Oslo, Norway,K. G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Clinical Medicine, University of Oslo,0318 Oslo, Norway;

    Cell and Developmental Biology, Department of Biology, University of Copenhagen, DK-2100 Copenhagen 0, Denmark;

    Life Sciences Division, Berkeley National Laboratory, Berkeley, CA 94720;

    Department of Cellular and Molecular Medicine, Centre for Biological Disease Analysis and Danish Stem Cell Centre, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    clonal isolation; ospective; signatures;

    机译:克隆隔离观点签名;
  • 入库时间 2022-08-18 00:40:19

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号